Polo-like kinase

Polo-like kinase
Name	Polo-like kinase

Polo-like kinase is a conserved serine/threonine kinase family central to mitotic control and cell-cycle progression. Members coordinate centrosome maturation, spindle assembly, chromosome segregation, and cytokinesis through phosphorylation of diverse substrates and recruitment of factors to subcellular structures. Discovered through genetic screens in model organisms, these kinases are studied across Saccharomyces cerevisiae, Drosophila melanogaster, Xenopus laevis, Mus musculus, and Homo sapiens for their roles in development and disease.

Structure and Domains

Members share a bi-partite architecture with an N‑terminal catalytic kinase domain homologous to those in the AGC kinase family, adjacent to a regulatory activation loop, and a C‑terminal polo‑box domain (PBD) that mediates phosphopeptide binding and substrate targeting. The PBD forms a tandem repeat resembling structures found in BRCT domains and engages phosphorylated motifs generated by priming kinases including Cyclin-dependent kinase 1 and Aurora kinase A. Linker regions between domains often harbor degrons recognized by the Anaphase-promoting complex and motifs for interaction with 14-3-3 proteins. Crystal structures from complexes with small molecules and peptide ligands have been solved using methods developed at facilities such as the European Synchrotron Radiation Facility and the Brookhaven National Laboratory.

Function and Cellular Roles

Polo‑box‑dependent localization directs kinase activity to centrosomes, kinetochores, midbodies, and the cleavage furrow, coordinating events from G2/M transition through cytokinesis. At centrosomes, phosphorylation of substrates like pericentrin homologs facilitates recruitment of γ‑tubulin ring complex components and spindle pole organization observed in studies using confocal microscopy and live imaging in Caenorhabditis elegans. At kinetochores, interactions with BubR1 and MAD1 integrate spindle assembly checkpoint signaling with error correction machineries including Protein phosphatase 1 and Chk1. During anaphase and telophase, localization to the central spindle regulates recruitment of the Centralspindlin complex and coordination with RhoA and Ect2 to execute cytokinesis; defects produce phenotypes documented in screens from the Wellcome Trust Sanger Institute and the European Molecular Biology Laboratory.

Regulation and Activation

Activation requires phosphorylation of the activation loop by upstream kinases such as Aurora A in complex with TPX2 and cofactors like Bora, while autophosphorylation and phosphatase interactions fine‑tune activity. Cell‑cycle–dependent expression is controlled by transcription factors including E2F1 and degradation by the SCF ubiquitin ligase and the Anaphase-promoting complex/Cdh1. Subcellular targeting via the PBD depends on priming phosphorylations by Cyclin-dependent kinase 1 and other kinases, and is antagonized by phosphatases including PP2A. Post‑translational modifications such as ubiquitination, sumoylation, and acetylation have been mapped using mass spectrometry pipelines pioneered at ProteomeXchange repositories and linked to cell‑cycle checkpoints characterized in Cold Spring Harbor Laboratory studies.

Polo-like Kinase Family Members

The family includes multiple paralogs with conserved and specialized roles: in vertebrates, prominent paralogs are Polo‑like kinase 1, Polo‑like kinase 2, Polo‑like kinase 3, and Polo‑like kinase 4; named members have been characterized in publications from institutions like National Institutes of Health and Max Planck Society. Polo‑like kinase 1 is essential for mitosis and is the best studied in mammalian systems; Polo‑like kinase 2 has roles in centriole duplication and neuronal signaling studied in models from Stanford University and University of Cambridge; Polo‑like kinase 3 participates in DNA damage responses linked to studies at the Fred Hutchinson Cancer Research Center; Polo‑like kinase 4 uniquely controls centriole biogenesis with self‑assembly properties explored in structural work at the European Bioinformatics Institute. Orthologs such as Cdc5 in Saccharomyces cerevisiae and Polo in Drosophila melanogaster illustrate conserved mechanisms revealed by genetic screens at The Rockefeller University.

Clinical Significance and Disease Associations

Dysregulation contributes to chromosomal instability, aneuploidy, and tumorigenesis implicated in cancers profiled by The Cancer Genome Atlas and analyzed at oncology centers like Memorial Sloan Kettering Cancer Center. Overexpression of Polo‑like kinase 1 correlates with poor prognosis in malignancies including breast cancer, lung cancer, colorectal cancer, and ovarian cancer in cohorts reported by major cancer consortia. Mutations or altered dosage of Polo‑like kinase 4 cause centriole amplification syndromes and congenital microcephaly described in clinical genetics clinics at Great Ormond Street Hospital and molecular diagnostics groups at Mayo Clinic. Roles in ischemia‑reperfusion injury and myocardial remodeling have been investigated by cardiovascular groups at Johns Hopkins Medicine.

Research Tools and Inhibitors

Research employs genetic tools such as conditional knockouts generated at Jackson Laboratory, RNAi libraries from the Broad Institute, CRISPR screens performed at MIT and live‑cell biosensors developed at Harvard Medical School to probe function. Small‑molecule inhibitors targeting the ATP pocket and PBD, including compounds evaluated in trials run by pharmaceutical companies like GlaxoSmithKline and Bayer, serve both as chemical probes and therapeutic leads; notable inhibitors advanced to clinical evaluation were tested in studies coordinated by National Cancer Institute consortia. Structural probes, peptide inhibitors modeled after phosphopeptide ligands, and proteomics approaches from European Proteomics Association provide complementary strategies to dissect substrates and signaling networks.

Category:Protein kinases Category:Cell cycle